The Clinical Infrastructure Core is an indispensable component of the SCCOR proposal. It is the unifying link? that serves each Project in a very specific manner by providing blood for DNA analysis and assorted? biochemistry determinations. Just as importantly, the Clinical Infrastructure Core collects, collates, files and? retrieves all clinical data, thereby matching each scientific analysis to key clinical information. Moreover, the? Clinical Infrastructure Core is responsible for recruiting patients, controls, and unique families for longitudinal? study. It is also responsible for the systematic follow-up of these patients and their families. In reality, this is an? enormous task, requiring the multiple interactions with patients, families, physicians, research nurses, scientists,? IRBs and administrators. Hundreds of samples will be acquired, stored, retrieved and analyzed. An? exceptionally large database of clinical, demographic, angiographic, electrocardiographic and echocardiographic? material will be generated and maintained. The group at the Cleveland Clinic has already assembled such an? organization on site in the form of GeneBank, GeneQuest, CHARISMA and carotid stenting. We have now? several years of experience with these two large and important data repositories, generously maintained by? strong institutional support. We have space and a large cadre of research nurses, computers, technicians and? some physicians to operate this labor-intensive infrastructure. Over time, its operational aspects have improved,? and important new data on genes and coronary artery disease are currently emerging. We now have an? opportunity with the SCCOR to expand our research goals and further link our clinical phenotype information in? the data banks to the genetic and molecular pathophysiology of coronary artery disease. The Clinical? Infrastructure Core is clearly essential to this end. We believe that under the able leadership of Drs. Gary? Francis and our many dedicated personnel, that we can leverage our unique experience with GeneBank and? GeneQuest to focus on new and tightly integrated SCCOR projects designed to explore and better understand the? genetics of thrombosis and resistance to anti-platelet agents.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL081011-02
Application #
7493852
Study Section
Special Emphasis Panel (ZHL1)
Project Start
2007-03-01
Project End
2011-02-28
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
2
Fiscal Year
2007
Total Cost
$239,207
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Wu, M; Barnard, J; Kundu, S et al. (2015) A novel pathway of cellular activation mediated by antiphospholipid antibody-induced extracellular vesicles. J Thromb Haemost 13:1928-40
Hajj-Ali, Rula A; Major, Jennifer; Langford, Carol et al. (2015) The interface of inflammation and subclinical atherosclerosis in granulomatosis with polyangiitis (Wegener's): a preliminary study. Transl Res 166:366-74
Chaturvedi, Shruti; Cockrell, Erin; Espinola, Ricardo et al. (2015) Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations. Thromb Res 135:102-8
Gupta, Nilaksh; Li, Wei; Willard, Belinda et al. (2014) Proteasome proteolysis supports stimulated platelet function and thrombosis. Arterioscler Thromb Vasc Biol 34:160-8
Li, Wei; Gigante, Alba; Perez-Perez, Maria-Jesus et al. (2014) Thymidine phosphorylase participates in platelet signaling and promotes thrombosis. Circ Res 115:997-1006
Srikanthan, S; Li, W; Silverstein, R L et al. (2014) Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions. J Thromb Haemost 12:1906-17
Timur, A Anil; Murugesan, Gurunathan; Zhang, Li et al. (2014) Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy. Thromb Res 134:96-104
Chaturvedi, Shruti; McCrae, Keith R (2014) Recent advances in the antiphospholipid antibody syndrome. Curr Opin Hematol 21:371-9
Zhao, Y; Xiong, Z; Lechner, E J et al. (2014) Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injury. Mucosal Immunol 7:440-8
Betapudi, Venkaiah; Lominadze, George; Hsi, Linda et al. (2013) Anti-?2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway. Blood 122:3808-17

Showing the most recent 10 out of 58 publications